Sign in

You're signed outSign in or to get full access.

James C. Thompson

Director at NATIONAL BANKSHARES
Board

About James C. Thompson

Independent director since 2017 (age 68); previously served on the Bank of Tazewell County board prior to its 2006 merger into National Bank of Blacksburg. Senior Project Manager at Thompson & Litton, Inc., where he has been employed since 1981; served on Thompson & Litton’s board for 38 years, including 15 years as Chairman. Brings executive management, finance, and strategic planning expertise; external leadership includes Chair of Carilion Tazewell Community Hospital, service on the Carilion Clinic board (Roanoke, VA), and the Tazewell Community Foundation board .

Past Roles

OrganizationRoleTenureCommittees/Impact
Bank of Tazewell CountyDirectorPre-2006 (merged into NBB in 2006)Community bank oversight; continuity through merger to NKSH bank
Thompson & Litton, Inc.Board Director; Chairman38 years; Chairman 15 yearsExecutive management, finance, strategic planning experience applied to NKSH board

External Roles

OrganizationRoleTenureNotes
Carilion Tazewell Community HospitalChairman of the BoardNot disclosedHealthcare governance leadership
Carilion Clinic (Roanoke, VA)Board of DirectorsNot disclosedRegional healthcare system governance
Tazewell Community FoundationBoard of DirectorsNot disclosedCommunity philanthropy governance

Board Governance

  • Independence: Independent under Nasdaq standards; only the CEO (Denardo) and President (Ramsey) are non-independent—others, including Thompson, are independent .
  • Committee assignments (2024): Not listed as a member of Executive, Audit, Compensation, Nominating, or Risk Committees (members identified; Thompson not among them) .
  • Attendance: Board met monthly (12 regular) plus 2 special meetings; all directors attended at least 75% of Board and committee meetings in 2024 .
  • Leadership: Combined Chair/CEO (Denardo); Lead Independent Director/Vice Chairman is Charles E. Green, III .
  • Stock ownership policy: Directors must hold shares worth ≥4x annual retainer (3-year phase-in from Jan 11, 2023 or appointment) .
  • Anti-hedging/pledging: Directors prohibited from hedging or pledging NKSH stock; no margin accounts permitted .
  • Executive sessions: Lead Independent Director presides when management excluded .

Fixed Compensation

Component2024 Structure/AmountThompson 2024 ReceivedNotes
Annual cash retainer$30,000Included in cash feesStandard non-employee director retainer
Board meeting fees$2,000 per regular/special meetingIncluded in cash feesPaid per meeting attended
Committee meeting fees$800 per meeting (unless concurrent with Board)N/A (not on standing committees in 2024)Applies if on committees
Equity retainerTime-based restricted stock; $14,000 grant-date fair value$14,000233 shares granted June 2024; 218 shares December 2024
Total cash fees (Thompson)$44,800Fees earned or paid in cash
Total compensation (Thompson)$58,800Cash $44,800 + Stock $14,000

Performance Compensation

  • Director equity is time-based restricted stock (not performance-linked); two grants in 2024 of 233 and 218 shares respectively, with aggregate grant-date fair value of $14,000 .
  • NKSH prohibits dividends on unvested awards under the 2023 Stock Incentive Plan and requires minimum one-year vesting; plan administered by the Compensation Committee (plan-wide features; director awards are time-based) .

Other Directorships & Interlocks

EntitySectorRolePotential Interlock/Conflict
Thompson & Litton, Inc.Engineering/Architecture/ConstructionSenior Project Manager; Director; former ChairmanNo related-party transactions disclosed involving Thompson; bank credits to directors are on market terms and standard risk
Carilion Tazewell Community HospitalHealthcareBoard ChairNo NKSH related-party transactions disclosed
Carilion ClinicHealthcareDirectorNo NKSH related-party transactions disclosed
Tazewell Community FoundationNon-profitDirectorNo NKSH related-party transactions disclosed

Expertise & Qualifications

  • Executive management, finance, strategic planning (via decades at Thompson & Litton; board leadership) .
  • Regional healthcare governance (Carilion boards) and community foundation oversight .

Equity Ownership

HolderShares Beneficially OwnedNotes
James C. Thompson9,128Includes 451 restricted shares subject to vesting; voting permitted on restricted shares
Directors’ ownership guidelines≥4× annual retainerThree-year phase-in from 1/11/2023 or appointment; compliance status not individually disclosed
Hedging/PledgingProhibitedApplies to all directors

Governance Assessment

  • Board effectiveness: Thompson contributes deep operating and strategic experience; however, he held no standing committee roles in 2024, which may limit direct influence over audit, compensation, nomination, and enterprise risk oversight relative to committee members .
  • Alignment: Time-based equity and a 4× retainer ownership requirement promote alignment; anti-hedging/pledging policy reduces misalignment risks .
  • Independence & attendance: Independent status and minimum attendance threshold met at Board level in 2024; supports investor confidence .
  • Conflicts/related parties: No transactions disclosed involving Thompson; board reviews related person transactions; loans to directors are on market terms and standard risk .
  • Shareholder sentiment: 2024 say‑on‑pay passed with 94% approval, indicating broad support for NKSH’s compensation governance framework (context for overall governance quality) .

Red flags

  • None disclosed for Thompson regarding related-party transactions, hedging/pledging, or attendance; absence of committee assignments could be viewed as a lower governance impact versus peers who chair or serve on key committees .